BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 38505563)

  • 1. Transcriptomic Profiling of Lactotroph Pituitary Neuroendocrine Tumors via RNA Sequencing and Ingenuity Pathway Analysis.
    Hattori Y; Tahara S; Ozawa H; Morita A; Ishii H
    Neuroendocrinology; 2024 Apr; ():1-11. PubMed ID: 38643763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the 2022 WHO Classification of Pituitary Tumors.
    Asa SL; Mete O; Perry A; Osamura RY
    Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy.
    Zhou Y; Zhang A; Fang C; Yuan L; Shao A; Xu Y; Zhou D
    CNS Neurosci Ther; 2023 Oct; 29(10):2744-2759. PubMed ID: 37341156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine Tumors.
    Jotanovic J; Tebani A; Hekmati N; Sivertsson Å; Lindskog C; Uhlèn M; Gudjonsson O; Tsatsaris E; Engström BE; Wikström J; Pontén F; Casar-Borota O
    J Endocr Soc; 2024 Mar; 8(5):bvae040. PubMed ID: 38505563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics.
    Bao X; Wang G; Yu S; Sun J; He L; Zhao H; Ma Y; Wang F; Wang X; Wang R; Yu J
    Theranostics; 2021; 11(1):132-146. PubMed ID: 33391466
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration.
    Feng T; Hou P; Mu S; Fang Y; Li X; Li Z; Wang D; Chen L; Lu L; Lin K; Wang S
    Lipids Health Dis; 2023 Aug; 22(1):127. PubMed ID: 37563740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis.
    Tebani A; Jotanovic J; Hekmati N; Sivertsson Å; Gudjonsson O; Edén Engström B; Wikström J; Uhlèn M; Casar-Borota O; Pontén F
    Acta Neuropathol Commun; 2021 Nov; 9(1):181. PubMed ID: 34758873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
    Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
    Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors.
    Wen S; Li J; Yang J; Li B; Li N; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():753606. PubMed ID: 34712204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Methylome and Transcriptome Signatures Expands the Molecular Classification of the Pituitary Tumors.
    Silva-Júnior RMPD; Bueno AC; Martins CS; Coelli-Lacchini F; Ozaki JGO; Almeida-E-Silva DC; Marrero-Gutiérrez J; Santos ACD; Garcia-Peral C; Machado HR; Santos MVD; Elias PL; Moreira AC; Colli LM; Vêncio RZN; Antonini SR; de Castro M
    J Clin Endocrinol Metab; 2023 May; 108(6):1452-1463. PubMed ID: 36504388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.
    Zhang F; Zhang Q; Zhu J; Yao B; Ma C; Qiao N; He S; Ye Z; Wang Y; Han R; Feng J; Wang Y; Qin Z; Ma Z; Li K; Zhang Y; Tian S; Chen Z; Tan S; Wu Y; Ran P; Wang Y; Ding C; Zhao Y
    Cell Res; 2022 Dec; 32(12):1047-1067. PubMed ID: 36307579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locus-Specific Enrichment Analysis of 5-Hydroxymethylcytosine Reveals Novel Genes Associated with Breast Carcinogenesis.
    Ramasamy D; Rao AKDM; Balaiah M; Vittal Rangan A; Sundersingh S; Veluswami S; Thangarajan R; Mani S
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non-small cell lung cancer.
    Dong Y; Zhao L; Duan J; Bai H; Chen D; Li S; Yu Y; Xiao M; Zhang Q; Duan Q; Sun T; Qi C; Wang J; Wang Z
    Cell Prolif; 2022 Sep; 55(9):e13283. PubMed ID: 35811392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior.
    Zhang D; Hugo W; Bergsneider M; Wang MB; Kim W; Vinters HV; Heaney AP
    Eur J Endocrinol; 2022 May; 187(1):49-64. PubMed ID: 35521707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer.
    Cao T; Lu Y; Wang Q; Qin H; Li H; Guo H; Ge M; Glass SE; Singh B; Zhang W; Dong J; Du F; Qian A; Tian Y; Wang X; Li C; Wu K; Fan D; Nie Y; Coffey RJ; Zhao X
    J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35289315
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.